SPIReL: PHASE 2 STUDY DPX‐SURVIVAC WITH INTERMITTENT LOW DOSE CYCLOPHOSPHAMIDE AND PEMBROLIZUMAB IN PATIENTS WITH RECURRENT/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMAN.L. Berinstein, I.A. Bence-Buckler, P. Laneuville,D. Stewart, L. Smyth, C. Kerr, G. Klein,N. Pennell, K. Roos-AssarHematological Oncology（2019）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
